Question 1

Indications?

Accepted Answer

This medication is a incretin mimetic, prescribed for type 2 diabetes with diet and exercise, either alone or with other medications.﻿‍‍‍‍‍‍​​​‍​​​​​​﻿   For patients with chronic kidney disease who are at elevated risk for CV events, a glucagon-like peptide 1 receptor agonist may lower risk for albuminuria progression and/or CV events, according to new (2019)recommendations of The American Diabet

Question 2

Side Effects?

Accepted Answer

Most Common
-    Nausea.
Central Nervous System
-    Dizziness or lightheadedness, nervousness, mood changes, weakness, shakiness, confusion, epilepsy and l﻿‍‍‍‍‍‍​​​‍​​​​​​﻿oss of consciousness.
Gastrointestinal
-     Extreme thirst, extreme hunger, stomach upset, vomiting, diarrhea and difficulty in swallowing.
Skin
-    Rash, hives and itching.
Allergic reactions
-    Swelling of the face, thro

Question 3

Warnings?

Accepted Answer

•Caution should be exercised in patients with history of gallstone disorder, smoking, drinking alcohol, who is taking other medications, any allergy, stomach, heart, li﻿‍‍‍‍‍‍​​​‍​​​​​​﻿ver, or kidney problems, during pregnancy and breastfeeding.
•     Patient may develop with low blood sugar, weight loss and decreased appetite; monitor blood sugar regularly while taking this medication.
•     It

Byetta Injection 0.25 mg/ml“U.K.”

User Reviews